Loading...
INICIO2019-12-02T13:51:45+01:00

At BIOHOPE we research and develop precision medicine IVD tools for chronic inflammatory conditions. Our lead product, IMMUNOBIOGRAM®, is a novel in vitro diagnostic kit which allows to optimize the immunosuppressive therapy in patients  with kidney transplantation and rheumatoid arthritis.

THE BIG CHALLENGE

CHRONIC INFLAMMATION is the “poor sister” of the big human diseases family. Infectious diseases, cancer, and many other diseases are managed under precision medicine protocols. On the contrary, chronic inflammation remains treated with immunosuppressive drugs mostly based on clinical guidelines, drug blood levels, and trial/error approaches.

Inflammatory diseases are clearly lacking a tool to determine the potency (efficacy) of immunosuppressive drugs over the immune cells of the patients, which are actually the target cells of the immunosuppressants/ immunomodulators.

ONE  TO ONE

PRECISION MEDICINE is the current major trend to maximize health outcomes in chronic medical conditions. This means that the time of “one drug for all” is over, instead, human diversity responses must be considered. Different patients need different drugs, and this is the driver of new medical management.

QUALITY OF LIFE

The IMMUNOBIOGRAM® is the only In Vitro Diagnostic test allowing the selection of the optimal immunosuppressive therapy (combination of drugs / dosage) for each patient at a specific point in time. More than 22 million patients worldwide can benefit from this unique technology.

G I V I N G    H O P E

Read more about me

LATEST NEWS